Evidence map›Paper›PMID 19602551›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2009

Differential activation of guinea pig intrinsic cardiac neurons by the PAC1 agonists maxadilan and pituitary adenylate cyclase-activating polypeptide 27 (PACAP27).

Donald B Hoover, John D Tompkins, Rodney L Parsons

Open access · greenAbstract readComparative Study
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Same same, but different: exploring the enigmatic role of the pituitary adenylate cyclase-activating polypeptide (PACAP) in invertebrate physiology.Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Donald B HooverDepartment of Pharmacology, East Tennessee State University, Johnson City, 37614, USA. hoover@etsu.edu
John D Tompkins
Rodney L Parsons
East Tennessee State University · US

Funding

Proteomics Core for Neuroscience P20 RR16435P20RR016435 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI ECKENSTEIN, FELIX P · 2001 to 2010
$23.5M
Modulation of parasympathetic neurons by PACAP peptidesR01HL065481 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI PARSONS, RODNEY L · 2002 to 2005
$1.2M
Role of Nonclassical Transmitters in Cardiac GangliaR01HL054633 · NHLBI · EAST TENNESSEE STATE UNIVERSITY · PI HOOVER, DONALD B · 1997 to 2004
$860k
Autonomic Control of Urinary Function in Diabetic MiceK01DK081444 · NIDDK · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TOMPKINS, JOHN DANIEL · 2008 to 2012
$611k
NCRR NIH HHS P20 RR016435NCRR NIH HHS P20-RR16435NHLBI NIH HHS HL54633NHLBI NIH HHS HL65481NHLBI NIH HHS R01 HL054633NHLBI NIH HHS R01 HL065481NIDDK NIH HHS K01 DK081444NIDDK NIH HHS K01-DK081444
6 · The paper itself

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) evokes tachycardia followed by a larger cholinergic bradycardia in isolated guinea pig hearts. We used the selective PAC1 receptor agonist maxadilan and vasoactive intestinal polypeptide (VIP) to test the hypothesis that PACAP27-evoked tachycardia and bradycardia are mediated by VPAC and PAC1 receptors, respectively. Chronotropic actions of these peptides were evaluated in isolated perfused hearts. Direct neuronal actions were determined by intracellular voltage recordings from cholinergic neurons in atrial ganglion whole mounts. Administration of 1 nmol of PACAP27 to isolated hearts evoked typical biphasic rate responses, whereas 1 nmol of maxadilan caused only a minor rate decrease. Desensitization with VIP eliminated the positive chronotropic effect of PACAP27 selectively. Local application of PACAP27 to cardiac neurons frequently evoked slow depolarization and caused prolonged increase of neuronal excitability. Maxadilan rarely affected membrane potential but consistently increased excitability. VIP had no effect on excitability and evoked depolarization in only a few neurons. Because maxadilan increased neuronal excitability but did not trigger action potentials as PACAP often does, we evaluated the interaction of maxadilan with substance P (SP) in isolated hearts. SP depolarizes cardiac neurons more consistently than PACAP, often triggers neuronal action potentials, and causes bradycardia but does not increase neuronal excitability. Maxadilan had a persistent effect to augment negative chronotropic responses to SP. These findings support our hypothesis that PACAP evokes tachycardia and bradycardia through VPAC and PAC1 receptors, respectively. They also suggest that maxadilan and PACAP27 differ in activating PAC1 receptors on cardiac neurons and/or stimulating downstream signaling mechanisms.

Indexed as

Action PotentialsAnimalsCells, CulturedFemaleGanglia, AutonomicGuinea PigsHeart Conduction SystemInsect ProteinsMaleNeuronsPituitary Adenylate Cyclase-Activating PolypeptideReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type ISalivary Proteins and PeptidesInsect Proteinsmaxadilan protein, insectPituitary Adenylate Cyclase-Activating PolypeptideReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type ISalivary Proteins and Peptides

Identifiers

PMID19602551
PMCPMC2766232
OpenAlexW2096284493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.